Life Sciences

Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 sp...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends in genetic engineering techniques across the United States. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of gene...

This edition of the Medical Device TOE depicts the current landscape and the new regional innovative trends in San Diego. Innovations in medical devices companies in San Diego are illustrated along with examples of few industry participants. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologi...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across immunotherapy. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportun...

13 Sep 2016  |  North America  |  Market Research

US Next-generation Sequencing Services Market

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

Infographics

×

The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across the pharmaceutical industry in South Africa. South Africa has a diversified manufacturing industry that focuses on production of pharmaceutical and biotechnology products. Critical programmes were launched by the Department of Trade and Indu...

The latest edition of the Medical Diagnostics and Imaging TOE depicts the current landscape and new trends across fluoroscopic imaging devices. Novel digital imaging solutions for fluoroscopy and radiography along with industry interactions have been presented. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to anal...